A newly established venture capital firm is focused on technologies that enhance the human experience and contribute to their well-being. For initial investment, the firm will invest $100-500K and will reserve some funds for follow-on investment. The firm invests mainly in Seed to Series A rounds and often acts as the first institutional investor. Currently, the firm is focused on investing in companies based in the USA, and aims to make 8-10 investments in bio/healthcare technologies.
The firm is interested in companies dedicated to genetics, microbiome, personal pharmaceuticals/diagnostics, VR/AR, consumer-facing medtech or digital health technologies, etc. The firm does not invest in traditional biopharmaceuticals or medical devices, but open to those that require 510k approval.
The firm is open to working with all types of management teams and has no specific management requirements. They could lead the round at seed stage but typically syndicate with other investors for Series A. The firm will take an active role in supporting their companies with needed guidance and resources.
If you are interested in more information about this investor and other investors tracked by LSN, please email mandates@lifesciencenation.com.
Leave a Reply